DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-125708 | Others
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Diagnosis and treatment of colorectal cancer Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET
7.1 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Exact Science Corporation
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Pathway Genomics Corporation
16.3 Sanofi
16.4 Taiho Pharma
16.5 Illumina
16.6 Roche
16.7 Rosetta Genomics
16.8 Onyx
16.9 Cancer Genetics
16.10 Merck KGaA
16.11 Bayer
16.12 Sysmex Corporation
16.13 Biocept
16.14 Takeda
16.15 Foundation Medicine
16.16 Eli Lilly
16.17 Regeneron
16.18 Amgen
16.19 Epigenomics
16.20 Danaher Corporation
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredDiagnosis of colorectal cancer
Treatment of colorectal cancer
Major Downstream Industry Covered
hospital
other
Specialist clinic
Companies
Exact Science Corporation
Pathway Genomics Corporation
Sanofi
Taiho Pharma
Illumina
Roche
Rosetta Genomics
Onyx
Cancer Genetics
Merck KGaA
Bayer
Sysmex Corporation
Biocept
Takeda
Foundation Medicine
Eli Lilly
Regeneron
Amgen
Epigenomics
Danaher Corporation
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.